Calls are growing louder in the U.S. and Europe for those governments to waive intellectual property rights for COVID-19 vaccines so developing countries would be able to manufacture their own jabs and narrow the current vaccine inequity gap.
These same appeals are also coming from within the foreign policy community who see the outsourcing of vaccine production to the Global South as a way to slow the soft power gains made by China and Russia’s highly-effective vaccine diplomacy campaign.
- Get a daily email packed with the latest China-Africa news and analysis.
- Read exclusive insights on the key trends shaping China-Africa relations.
- Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.